# Study to Evaluate the Efficacy and Safety of PF-06480605 in Adult Participants With Moderate to Severe Crohn's Disease

> **NCT05471492** · PHASE2 · WITHDRAWN · sponsor: **Telavant, Inc.**

## Conditions studied

- Crohn Disease

## Interventions

- **DRUG:** Investigational Product
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05471492
- **Lead sponsor:** Telavant, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-07-30
- **Primary completion:** 2026-08-15
- **Final completion:** 2026-08-15
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Trial not started; change in Sponsor, a new trial to be registered by the new Sponsor
- **Last updated:** 2023-10-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05471492

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05471492, "Study to Evaluate the Efficacy and Safety of PF-06480605 in Adult Participants With Moderate to Severe Crohn's Disease". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05471492. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*